Neuromodulation: Factors associated with pain at the implantation site of an implantable pulse generator, a multicenter cross-sectional study

Electrical stimulation of the dorsal spinal column for the treatment of intractable pain was first described by Shealy et al
.

In 1967, the clinical application of neuromodulation systems developed rapidly

In addition, patient demographics have shifted from predominantly older male patients to increasingly including pediatric, adolescent, and female patients

Little is known about the ideal anatomical location for IPG placement to minimize the likelihood of chronic IPG placement site pain, a gap in clinical knowledge in an era of increasing use of neuromodulation procedures
.

In this study, this article sought to determine whether the anatomical location of IPG placement is associated with chronic IPG-related pain in patients with permanently implanted neuromodulation systems

This article assessed the incidence, severity, and quality of pain at the IPG site, as well as IPG-related pain management needs, functional impairment, and patient assessments of cosmetic appearance

This study was an IRB-approved, multicenter, cross-sectional survey of patients treated at two tertiary care centers
.

Patients who received a permanent neurostimulation system with an IPG (spinal cord stimulator, deep brain stimulator, sacral nerve stimulator) between January 1, 2010 and December 31, 2015

Demographic data, diagnosis , IPG anatomical site, IPG implantation date, IPG type, incidence of hematoma or infection at the IPG site, and incidence of hand at the IPG site were collected from each participant's medical records

patient characteristics

The overall survey response rate was 60.
5% (n = 510)
.

Overall, 31.

Compared with deep brain stimulators or sacral neurostimulators, the most important factor for pain associated with the IPG site is the implanted spinal cord stimulator

Quality of Life

Choi, H.

Choi, H.

leave a message here